Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1208/s12249-024-02897-5
Read article for free, from open access legal sources, via Unpaywall: https://link.springer.com/content/pdf/10.1208/s12249-024-02897-5.pdf
References
Articles referenced by this article (1)
DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer.
Int J Biol Macromol, 413-425 2020
MED: 32057849
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
AAPS PharmSciTech, 21(5):151, 21 May 2020
Cited by: 16 articles | PMID: 32440910
Correction to: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
AAPS PharmSciTech, 21(6):207, 27 Jul 2020
Cited by: 0 articles | PMID: 32720079
[Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer].
Zhongguo Zhong Yao Za Zhi, 48(13):3472-3484, 01 Jul 2023
Cited by: 4 articles | PMID: 37474984
Delivery of Apoptosis-inducing Piperine to Triple-negative Breast Cancer Cells via Co-polymeric Nanoparticles.
Anticancer Res, 40(2):689-694, 01 Feb 2020
Cited by: 8 articles | PMID: 32014909